Cargando…

Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection

Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yorozu, Keigo, Kurasawa, Mitsue, Iino, Yuki, Nakamura, Yuka, Hashizume, Kaoru, Harada, Naoki, Ochiai, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100237/
https://www.ncbi.nlm.nih.gov/pubmed/36398869
http://dx.doi.org/10.1111/pin.13288
_version_ 1785025232674750464
author Yorozu, Keigo
Kurasawa, Mitsue
Iino, Yuki
Nakamura, Yuka
Hashizume, Kaoru
Harada, Naoki
Ochiai, Atsushi
author_facet Yorozu, Keigo
Kurasawa, Mitsue
Iino, Yuki
Nakamura, Yuka
Hashizume, Kaoru
Harada, Naoki
Ochiai, Atsushi
author_sort Yorozu, Keigo
collection PubMed
description Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting the importance of improving HER2 detection accuracy in clinical practice. We prepared tissue microarray (TMA) slides for use as control slides for the standardization of gastric HER2 testing. Four human gastric cancer cell lines with HER2 scores of 3+, 2+, 1+, and 0 were xenografted in NOG mice. The TMA slides were constructed using samples from three different areas in these tumors. Staining properties were determined using six clinical kits for HER2. In TMA, HER2‐positive tumors with HER2 scores of 3+ and 2+ showed good staining with all diagnostic kits, and the tissue images were similar to those of clinical samples. Xenograft tumor slides could potentially be used as external controls to standardize staining conditions for a variety of kits and may improve the accuracy of HER2 detection in clinical practice.
format Online
Article
Text
id pubmed-10100237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101002372023-04-14 Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection Yorozu, Keigo Kurasawa, Mitsue Iino, Yuki Nakamura, Yuka Hashizume, Kaoru Harada, Naoki Ochiai, Atsushi Pathol Int Short Communication Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting the importance of improving HER2 detection accuracy in clinical practice. We prepared tissue microarray (TMA) slides for use as control slides for the standardization of gastric HER2 testing. Four human gastric cancer cell lines with HER2 scores of 3+, 2+, 1+, and 0 were xenografted in NOG mice. The TMA slides were constructed using samples from three different areas in these tumors. Staining properties were determined using six clinical kits for HER2. In TMA, HER2‐positive tumors with HER2 scores of 3+ and 2+ showed good staining with all diagnostic kits, and the tissue images were similar to those of clinical samples. Xenograft tumor slides could potentially be used as external controls to standardize staining conditions for a variety of kits and may improve the accuracy of HER2 detection in clinical practice. John Wiley and Sons Inc. 2022-11-18 2023-01 /pmc/articles/PMC10100237/ /pubmed/36398869 http://dx.doi.org/10.1111/pin.13288 Text en © 2022 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Short Communication
Yorozu, Keigo
Kurasawa, Mitsue
Iino, Yuki
Nakamura, Yuka
Hashizume, Kaoru
Harada, Naoki
Ochiai, Atsushi
Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title_full Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title_fullStr Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title_full_unstemmed Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title_short Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
title_sort methods for preparing tissue microarray slides using xenografts with different levels of her2 expression to standardize her2 detection
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100237/
https://www.ncbi.nlm.nih.gov/pubmed/36398869
http://dx.doi.org/10.1111/pin.13288
work_keys_str_mv AT yorozukeigo methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT kurasawamitsue methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT iinoyuki methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT nakamurayuka methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT hashizumekaoru methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT haradanaoki methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection
AT ochiaiatsushi methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection